Role of Chemokines in Angiogenesis: CXCL12/SDF-1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses

REFERENCES

• Addison CL, Arenberg DA, Morris SB, Xue YY, Bur-dick MD, Mulligan MS, Iannettoni MD, Strieter RM. (2000). The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carci-noma tumor growth and metastasis. Hum Gene Ther 11:247–261.
   PubMed Web of Science ®Google Scholar
• Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. (1997). The chemokine SDF-1 is a che-moattractant for human CD34+ hematopoietic pro-genitor cells and provides a new mechanism to ex-plain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111–120.
   PubMed Web of Science ®Google Scholar
• Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Bur-dick MD, Strieter RM. (1996). Inhibition of interleu-kin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97:2792–2802.
   PubMed Web of Science ®Google Scholar
• Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM. (1996). Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 184:981–992.
   PubMed Web of Science ®Google Scholar
• Auerbach W, Auerbach R. (1994). Angiogenesis in-hibition: a review. Pharmacol Ther 63:265–311.
   PubMed Web of Science ®Google Scholar
• Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640–644.
   PubMed Web of Science ®Google Scholar
• Begum NA, Coker A, Shibuta K, Swanson RS, Chen LB, Mori M, Barnard GF. (1996). Loss of hIRH mRNA expression from premalignant adenomas and malignant cell lines. Biochem Biophys Res Commun 229:864–868.
   Google Scholar
• Berger O, Gan X, Gujuluva C, Burns AR, Sulur G, Stins M, Way D, Witte M, Weinand M, Said J, Kim KS, Taub D, Graves MC, Fiala M. (1999). CXC and CC chemokine receptors on coronary and brain en-dothelia. Mol Med 5:795–805.
   PubMed Web of Science ®Google Scholar
• Bernardini G, Spinetti G, Ribatti D, Camarda G, Mor-bidelli L, Ziche M, Santoni A, Capogrossi MC, Napolitano M. (2000). 1–309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 96:4039–4045.
   Google Scholar
• Bertolini F, Dell'Agnola C, Mancuso P. Rabascio C, Burlini A, Monestiroli S, Gobbi A, Pruneri G, Marti-nelli G. (2002). CXCR4 neutralization, a novel thera-peutic approach for non-Hodgkin's lymphoma. Can-cer Res 62:3106–3112.
   PubMed Web of Science ®Google Scholar
• Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ. (1998). Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Der-matol 111:864–872.
   PubMed Web of Science ®Google Scholar
• Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler U. (1999). Progressive growth of infantile cutaneous hemangiomas is directly corre-lated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 14:401–408.
   Google Scholar
• Bowersox JC, Sorgente N. (1982). Chemotaxis of aor-tic endothelial cells in response to fibronectin. Cancer Res 42:2547–2551.
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen C, Weatherbee JA, Tsang M, Folkman J. (1995). gro-beta, a -C-X-C- chemokine, is an angio-genesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 182:2069–2077.
   PubMed Web of Science ®Google Scholar
• Connolly DT, Stoddard BL, Harakas NK, Feder J. (1987). Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells. Biochem Biophys Res Commun 144:705–712.
   PubMedGoogle Scholar
• Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ. (1998). Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by sys-temic interferon-alpha administration. Cancer Res 58:808–814.
   PubMed Web of Science ®Google Scholar
• Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler U. (1999). Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engi-neered to produce interferon-beta. Cancer Res 59: 872–879.
   PubMed Web of Science ®Google Scholar
• Ellis LM, Fidler U. (1996). Angiogenesis and metas-tasis. Eur J Cancer 32A:2451–2460.
   PubMed Web of Science ®Google Scholar
• Engelhardt E, Toksoy A, Goebeler M, Debus S. Brocker EB, Gillitzer R. (1998). Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific in- filtration of leukocyte subsets in human wound heal-ing. Am J Pathol 153:1849–1860.
   PubMed Web of Science ®Google Scholar
• Ezekowitz RA, Mulliken JB, Folkman J. (1992). In-terferon alfa-2a therapy for life-threatening heman-giomas of infancy. N Engl J Med 326:1456–1463.
   PubMed Web of Science ®Google Scholar
• Feil C, Augustin HG. (1998). Endothelial cells differ-entially express functional CXC-chemokine recep-tor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 247:38–45.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. (1991). The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211–218.
   PubMed Web of Science ®Google Scholar
• Fidler IJ, Kumar R, Bielenberg DR, Ellis LM. (1998). Molecular determinants of angiogenesis in cancer me-tastasis. Cancer J Sci Am 4:S58–S66.
   Google Scholar
• Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1996). Fighting cancer by attacking its blood supply. Sci Am 275:150–154.
   PubMed Web of Science ®Google Scholar
• Folkman J, Hanahan D. (1991). Switch to the angio-genic phenotype during tumorigenesis. Princess Takamatsu Symp 22:339–347.
   PubMedGoogle Scholar
• Folkman J, Watson K, Ingber D, Hanahan D. (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61.
   PubMed Web of Science ®Google Scholar
• Fox JA, Ung K, Tanlimco SG, Jirik FR. (2002). Dis-ruption of a single Pten allele augments the chemo-tactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol 169:49–54.
   PubMed Web of Science ®Google Scholar
• Friesel RE, Maciag T. (1995). Molecular mechanisms of angiogenesis: fibroblast growth factor signal trans-duction. FASEB J 9:919–925.
   PubMed Web of Science ®Google Scholar
• Glaser BM, D'Amore PA, Lutty GA, Fenselau AH, Michels RG, Patz A. (1980). Chemical mediators of intraocular neovascularization. Trans Ophthalmol Soc UK 100:369–373.
   Google Scholar
• Glaser BM, D'Amore PA, Seppa H, Seppa S, Schiff-mann E. (1980). Adult tissues contain chemoat-tractants for vascular endothelial cells. Nature 288: 483–484.
   PubMed Web of Science ®Google Scholar
• Goldberg SH, van der Meer P. Hesselgesser J, Jaffer S, Kolson DL, Albright AV, Gonzalez-Scarano F, Lavi E. (2001). CXCR3 expression in human central ner-vous system diseases. Neuropathol Appl Neurobiol 27:127–138.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. (1998). Chemokine receptors in human endothelial cells: functional expression of CXCR4 and its transcriptional regulation by inflammatory cyto-kines. J Biol Chem 273:4282–4287.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. (1996). Patterns and emerg-ing mechanisms of the angiogenic switch during tu-morigenesis. Cell 86:353–364.
   PubMed Web of Science ®Google Scholar
• Imai K, Kobayashi M, Wang J, Shinobu N, Yoshida H, Hamada J, Shindo M, Higashino F, Tanaka J, Asaka M, Hosokawa M. (1999). Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in hom-ing of haemopoietic progenitor cells to bone marrow. Br J Haematol 106:905–911.
   PubMed Web of Science ®Google Scholar
• Jenh CH, Cox MA, Hipkin W, Lu T, Pugliese-Sivo C, Gonsiorek W, Chou CC, Narula SK, Zavodny PJ. (2001). Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 re-ceptor. Cytokine 15:113–121.
   PubMed Web of Science ®Google Scholar
• Joseph-Silverstein J, Rifkin DB. (1987). Endothelial cell growth factors and the vessel wall. Semin Thromb Hemost 13:504–513.
   PubMed Web of Science ®Google Scholar
• Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. (1991). Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095–1104.
   PubMed Web of Science ®Google Scholar
• Kijowski J, Baj-Krzyworzeka M, Majka M, Reca R, Marquez LA, Christofidou-Solomidou M, Janowska-Wieczorek A, Ratajczak MZ. (2001). The SDF -1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells 19:453–466.
   PubMed Web of Science ®Google Scholar
• Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPi-etro LA, Elner VM, Elner SG, Strieter RM. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798–1801.
   PubMed Web of Science ®Google Scholar
• Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Honi T, Fujii N, Imamura M. (2000). Expression of stro-mal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6:3530–3535.
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Sasada R, Iwane M, Igarashi K. (1987). Cloning and expression of cDNA encoding human ba-sic fibroblast growth factor. FEBS Lett 213:189–194.
   PubMed Web of Science ®Google Scholar
• Lavi E, Kolson DL, Ulrich AM, Fu L, Gonzalez-Scarano F. (1998). Chemokine receptors in the hu-man brain and their relationship to HIV infection. J Neurovirol 4:301–311.
   PubMed Web of Science ®Google Scholar
• Luster AD, Greenberg SM, Leder P. (1995). The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182:219–231.
   PubMed Web of Science ®Google Scholar
• Maciag T, Friesel RE. (1995). Molecular mechanisms of fibroblast growth factor-1 traffick, signaling and release. Thromb Haemost 74:411–414.
   PubMed Web of Science ®Google Scholar
• Millauer B, Wizigmann-Voos S, Schnurch H, Mar-tinez R, Moller NP, Risau W, Ullrich A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835–846.
   PubMed Web of Science ®Google Scholar
• Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V. Legrand E, Vannier J, Soria J, Vasse M, Soria C. (2000). SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res 99:587–594.
   PubMed Web of Science ®Google Scholar
• Mitra P. Shibuta K, Mathai J, Shimoda K, Banner BF, Mori M, Barnard GF. (1999). CXCR4 mRNA expres-sion in colon, esophageal and gastric cancers and hepatitis C infected liver. Int J Oncol 14:917–925.
   Google Scholar
• Molino M, Woolkalis MJ, Prevost N, Pratico D, Bar-nathan ES, Taraboletti G, Haggarty BS, Hesselgesser J, Horuk R, Hoxie JA, Brass LF. (2000). CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. Biochim Biophys Acta 1500:227–240.
   PubMed Web of Science ®Google Scholar
• Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlot-nik A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56.
   PubMed Web of Science ®Google Scholar
• Murdoch C, Monk PN, Finn A. (1999). CXC chemo-kine receptor expression on human endothelial cells. Cytokine 11:704–712.
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Kikutani H, Kishimoto T. (1994). Mo-lecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Nall Acad Sci USA. 91:2305–2309 .
   PubMed Web of Science ®Google Scholar
• Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833–835.
   PubMed Web of Science ®Google Scholar
• Pablos JL, Amara A, Bouloc A, Santiago B, Caruz A, Galindo M, Delaunay T, Virelizier JL, Arenzana-Seisdedos F. (1999). Stromal-cell derived factor is expressed by dendritic cells and endothelium in hu-man skin. Am J Pathol 155:1577–1586.
   PubMed Web of Science ®Google Scholar
• Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Aren-zana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T. (2002). G-CSF induces stem cell mobili-zation by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687–694.
   PubMed Web of Science ®Google Scholar
• Regulier E, Paul S, Marigliano M, Kintz J, Poitevin Y, Ledoux C, Roecklin D, Cauet G, Calenda V, Homann HE. (2001). Adenovirus-mediated delivery of antian-giogenic genes as an antitumor approach. Cancer Gene Ther 8:45–54.
   PubMed Web of Science ®Google Scholar
• Rempel SA, Dudas S, Ge S, Gutierrez JA. (2000). Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to re-gions of necrosis and angiogenesis in human glioblas-toma. Clin Cancer Res 6:102–111.
   PubMed Web of Science ®Google Scholar
• Risau W, Flamme I. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11:73–91.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. (1997). Chemokines. Blood 90:909–928.
   PubMed Web of Science ®Google Scholar
• Romagnani P. Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Ro-magnani S, Serio M. (2001). Cell cycle-dependent ex-pression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107: 53–63.
   Google Scholar
• Ruth JH, Volin MV, Haines GK 3rd, Woodruff DC, Katschke KJ Jr, Woods JM, Park CC, Morel JC, Koch AE. (2001). Fractalkine, a novel chemokine in rheu-matoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 44:1568–1581.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. (2000). Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogen-esis and tumor progression. Blood 96:34–40.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Resau JH, Halverson D, Hudson EA, Dam-bach M, Powell D, Wasserman K, Oppenheim JJ. (2000). Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human micro-vascular endothelial cells and umbilical vein endothe-lial cells. FASEB J 14:2055–2064.
   Google Scholar
• Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. (1999). Vascular endothelial growth factor and basic fibroblast growth factor induce ex-pression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor- 1 alpha. Am J Pathol 154:1125–1135.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Young HA, Ponce ML, Ward JM, Klein-man HK, Murphy WJ, Oppenheim JJ. (2001). Eo-taxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 166: 7571–7578.
   PubMed Web of Science ®Google Scholar
• Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. (2002). Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99:2703–2711.
   PubMed Web of Science ®Google Scholar
• Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P. Atzpodien J, Buer J, Lauber J. (2002). CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86:1250–1256.
   PubMed Web of Science ®Google Scholar
• Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP. (1998). CXCR-4, a chemokine receptor, is over-expressed in and required for proliferation of glio-blastoma tumor cells. J Surg Oncol 69:99–104.
   PubMed Web of Science ®Google Scholar
• Sehgal A, Ricks S, Boynton AL, Warrick J, Murphy GP. (1998). Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J Surg Oncol 69:239–248.
   PubMed Web of Science ®Google Scholar
• Seppa ST, Seppa HE, Liotta LA, Glaser BM, Martin GR, Schiffmann E. (1983). Cultured tumor cells pro-duce chemotactic factors specific for endothelial cells: a possible mechanism for tumor-induced angiogene-s is . Invasion Metastasis 3:139–150.
   Google Scholar
• Sgadari C, Angiolillo AL, Cherney BW, Pike SE, Far-ber JM, Koniaris LG, Vanguri P. Burd PR, Sheikh N, Gupta G, Teruya-Feldstein J, Tosato G. (1996). In-terferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Nall Acad Sci USA. 93: 13791–13796.
   Google Scholar
• Sgadari C, Farber JM, Angiolillo AL, Liao F, Teruya-Feldstein J, Burd PR, Yao L, Gupta G, Kanegane C, Tosato G. (1997). Mig, the monokine induced by in-terferon-gamma, promotes tumor necrosis in vivo. Blood 89:2635–2643.
   PubMed Web of Science ®Google Scholar
• Shibuta K, Begum NA, Mori M, Shimoda K, Akiyoshi T, Barnard GF. (1997). Reduced expression of the CXC chemokine hIRH/SDF- 1 alpha mRNA in hepa-toma and digestive tract cancer. Int J Cancer 73:656–662 .
   Google Scholar
• Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T. (1995). Structure and chro-mosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495–500.
   PubMed Web of Science ®Google Scholar
• Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM. (1994). Inhibition of interleukin 8 attenuates angio-genesis in bronchogenic carcinoma. J Exp Med 179: 1409–1415.
   PubMed Web of Science ®Google Scholar
• Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, Zlotnik A. (1998). The CC chemokine 6Ckine binds the CXC chemokine recep-tor CXCR3. Proc Nall Acad Sci USA. 95:8205–8210.
   PubMed Web of Science ®Google Scholar
• Spinetti G, Camarda G, Bernardini G, Romano Di Peppe S, Capogrossi MC, Napolitano M. (2001). The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells. Biochem Biophys Res Commun 289:19–24.
   Google Scholar
• Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL. (1995). The role of CXC chemokines as regulators of angiogenesis. Shock 4:155–160.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, et al. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogene-sis. J Biol Chem 270:27348–27357.
   PubMed Web of Science ®Google Scholar
• Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawa-bata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T. (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Na-ture 393:591–594.
   PubMed Web of Science ®Google Scholar
• Terranova VP, DiFlorio R, Lyall RM, Hie S, Friesel R, Maciag T. (1985). Human endothelial cells are che-motactic to endothelial cell growth factor and hepa-rin. J Cell Biol 101:2330–2334.
   PubMed Web of Science ®Google Scholar
• Van Der Meer P, Goldberg SH, Fung KM, Sharer LR, Gonzalez-Scarano F, Lavi E. (2001). Expression pat-tern of CXCR3, CXCR4, and CCR3 chemokine recep-tors in the developing human brain. J Neuropathol Exp Neurol 60:25–32.
   PubMed Web of Science ®Google Scholar
• Volin MV, Joseph L, Shockley MS, Davies PF. (1998). Chemokine receptor CXCR4 expression in en-dothelium. Biochem Biophys Res Commun 242:46–53.
   PubMedGoogle Scholar
• Volin MV, Woods JM, Amin MA, Connors MA, Har-low LA, Koch AE. (2001). Fractalkine: a novel an-giogenic chemokine in rheumatoid arthritis. Am J Pathol 159:1521–1530.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang X, Ward AC, Touw IP, Friedman AD. (2001). C/EBPalpha and G-CSF receptor signals co-operate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia 15:779–786.
   PubMed Web of Science ®Google Scholar
• Weber KS, Nelson PJ, Grone HJ, Weber C. (1999). Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085–2093.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. (1997). Involvement of inter-leukin-8, vascular endothelial growth factor, and ba-sic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17: 4015–4023.
   PubMed Web of Science ®Google Scholar
• Zetter BR. (1980). Migration of capillary endothelial cells is stimulated by tumour-derived factors. Nature 285:41–43.
   PubMed Web of Science ®Google Scholar